• Dry Cracked Skin
  • Impetigo
  • Aesthetics
  • Vitiligo
  • COVID-19
  • Actinic Keratosis
  • Precision Medicine and Biologics
  • Rare Disease
  • Wound Care
  • Rosacea
  • Psoriasis
  • Psoriatic Arthritis
  • Atopic Dermatitis
  • Surgery
  • Melasma
  • NP and PA
  • Anti-Aging
  • Skin Cancer
  • Hidradenitis Suppurativa
  • Drug Watch
  • Pigmentary Disorders
  • Acne
  • Pediatric Dermatology
  • Practice Management
  • Inflamed Skin

New agents show promise in melanoma

Article

Tampa, Fla. — Among molecularly targeted agents being developed to treat melanoma, some of the most exciting are anti-CTLA-4 antibodies now being developed by Pfizer and Medarex.

Related Videos
Related Content
Exploring the Relationship Between AD, Psychological Stress, Sleep Disturbances, and Salivary Biomarkers

Exploring the Relationship Between AD, Psychological Stress, Sleep Disturbances, and Salivary Biomarkers

Article
The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients

The Cutaneous Connection: Pearls for Atopic Dermatitis in College-Aged Patients

Podcast
What Conferences Are You Planning to Attend in Quarter 1 of 2024?

What Conferences Are You Planning to Attend in Quarter 1 of 2024?

Article
The Cutaneous Connection: Understanding Age-Approved Therapies in the Atopic Dermatitis Armamentarium

The Cutaneous Connection: Understanding Age-Approved Therapies in the Atopic Dermatitis Armamentarium

Podcast
Skin Cancer Detection With AI: How Intelligent Is It?

Skin Cancer Detection With AI: How Intelligent Is It?

Article
POLL: Have Your Patients Asked About Cabtreo for Acne?

POLL: Have Your Patients Asked About Cabtreo for Acne?

Article
© 2023 MJH Life Sciences

All rights reserved.